Benmoussa Kevin 4
4 · Vita Coco Company, Inc. · Filed Aug 24, 2022
Insider Transaction Report
Form 4
Benmoussa Kevin
Chief Financial Officer
Transactions
- Sale
Common Stock
2022-08-22$15.54/sh−15,000$233,100→ 10,150 total - Exercise/Conversion
Common Stock
2022-08-22$10.18/sh+15,000$152,670→ 25,150 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-08-22−15,000→ 2,375 totalExercise: $10.18Exp: 2029-12-16→ Common Stock (15,000 underlying)
Holdings
- 56,875
Stock Option (Right to Buy)
Exercise: $10.18Exp: 2030-02-10→ Common Stock (56,875 underlying) - 49,751
Stock Option (Right to Buy)
Exercise: $15.00Exp: 2031-10-20→ Common Stock (49,751 underlying) - 27,300
Stock Option (Right to Buy)
Exercise: $10.18Exp: 2031-01-11→ Common Stock (27,300 underlying)
Footnotes (6)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.41 to $15.74, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F2]Includes (i) 10,000 unvested RSUs that vest in four annual installments starting November 27, 2022 provided that the Reporting Person remains in continuous service on each vesting date and (ii) 150 shares of common stock purchased directly from the issuer's underwriters in a Reserved Share Program.
- [F3]The stock option is fully vested and currently exercisable.
- [F4]The stock option vests on February 10, 2024.
- [F5]The stock option vests in two equal biennial installments beginning on January 11, 2023.
- [F6]The stock option vests in four equal annual installments beginning on November 27, 2022.